跳至主要内容
临床试验/NCT02862795
NCT02862795已完成不适用

Human PapillomaVirus (HPV) Anal Infection: Study of Prevalence and Risk Factors Among 1000 Patients Benefiting From a Colonoscopy

Centre Hospitalier Universitaire de Besancon4 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2012年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
500
试验地点
4
主要终点
anal canal HPV infection

研究概览

简要总结

Human papillomavirus (HPV) are involved in up to 95 % of anal canal neoplastic lesions. Little is known about HPV carriage in anal canal previous to cancer occurrence in the population and pre-neoplastic lesions, and their risk factors. PAPILLAN is a prospective study that aims to study HPV infection (HPV low grade and high grade genotypes) prevalence in anal canal in a population non selected by its HIV status. In that purpose patients are prospectively recruited in a french university hospital gastroenterology unit and anal smears are collected during a colonoscopy with cytobrush.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients > 18 years
  • patients undergoing colonoscopy under general anesthesia for any purpose
  • signed written consent

排除标准

  • age under 18
  • Absence of written consent.
  • patients incapable of giving consent

结局指标

主要结局

anal canal HPV infection

时间窗: at inclusion (the day of colonoscopy)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验